Wesley D. Kufel

Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections

Katie A Parsels, Keri A. Mastro, Jeffrey M. Steele et al. · Journal of Antimicrobial Chemotherapy · 2021 · 71 citations

Antibiotic Adjuvant, Klebsiella Pneumoniae, Immunology +22

Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia

Bryan T. Mogle, Jeffrey M. Steele, Robert W. Seabury et al. · International Journal of Antimicrobial Agents · 2018 · 56 citations

Therapeutic Drug Monitoring, Antimicrobial Susceptibility, Antibiotics +8

Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i>

Sara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette et al. · Open Forum Infectious Diseases · 2021 · 51 citations · Full text

Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study

Ryan K. Shields, Lilian M. Abbo, Renee Ackley et al. · The Lancet Infectious Diseases · 2024 · 38 citations

Antimicrobial Susceptibility, Antibiotics, Medicine +11

Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant <i>Acinetobacter baumannii</i> meningitis

Wesley D. Kufel, Yasmeen Abouelhassan, Jeffrey M. Steele et al. · Journal of Antimicrobial Chemotherapy · 2022 · 31 citations